Topoisomerase I is essential in Cryptococcus neoformans: Role in pathobiology and as an antifungal target

Genetics

Volumn 152, Issue 1, 1999, Pages 167-178

  Del Poeta, Maurizio ^a,b   Toffaletti, Dena L ^a   Rude, Thomas H ^a   Dykstra, Christine C ^c   Heitman, Joseph ^a   Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL VIABILITY; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; FUSION GENE; GENE DISRUPTION; GENE INSERTION; GENE OVEREXPRESSION; GENETIC RECOMBINATION; HEAT SENSITIVITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RADIOSENSITIVITY; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANIMALS; BIOTRANSFORMATION; CAMPTOTHECIN; CELL SURVIVAL; CLONING, MOLECULAR; CRYPTOCOCCUS; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; GENE EXPRESSION; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PLASMIDS; RABBITS; RADIATION, IONIZING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS;

ANIMALIA; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 0032900947     PISSN: 00166731     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. ALSPAUGH, J. A., J. R. PERFECT and J. HEITMAN, 1997 Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev. 11: 3206-3217.
2. ARMENGOU, A., C. PORCAR, J. MASCARO and F. GARCIA-BRAGADO, 1996 Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin. Infect. Dis. 23: 1337-1338.
3. BERG, J., C. J. CLANCY and M. H. NGUYEN, 1998 The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin. Infect. Dis. 26: 186-187.
4. BERNHAM, D. R., A. TRIVEDI, P. WEINBERGER and R. E. J. MITCHELL, 1990 The involvement of topoisomerases and DNA polymerase I in the mechanism of induced thermal and radiation resistance in yeast. Radiat. Res. 123: 203-212.
5. BIRLEY, H. D., E. M. JOHNSON, P. MCDONALD, C. PARRY, P. B. CAREY et al., 1995 Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis. Int. J. STD AIDS 6: 353-355.
6. BOHR, V. A., 1988 DNA repair and transcriptional activity in genes. J. Cell Sci. 90: 175-178.
7. BRILL, S., S. DINARDO, K. VOELKEL-MEINMAN and R. STERNGLANZ, 1987 Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. Nature 326: 414-415.
8. BRONSTEIN, I. B., S. VOROBYEV, A. TIMOFEEV, C. J. JOLLES, S. L. ALDER et al., 1996 Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignancies. Oncol. Res. 8: 17-25.
9. CASTANO, I. B., P. M. BRZOSKA, B. U. SADOFF, H. CHEN AND M. F. CHRISTMAN, 1996 Mitotic chromosome condensation in the rDNA requires TRF4 and DNA topoisomerase in Saccharomyces cerevisiae. Genes Dev. 10: 2564-2576.
10. CHRISTMAN, M. F., F. S. DIETRICH and G. R. FINK, 1988 Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II. Cell 55: 413-425.
11. COX, G. M., T. H. RUDE, C. C. DYKSTRA and J. R. PERFECT, 1995 The actin gene from Cryptococcus neoformans: structure and phylogenetic analysis. J. Med. Vet. Mycol. 33: 261-266.
12. DEL POETA, M., W. A. SCHELL, C. C. DYKSTRA, S. K. JONES, R. R. TIDWELL et al., 1998a Structure-in vitro activity relationship of pentamidine analogous and dicationic substituted bis-benzimidazoles as new antifungal agents. Antimicrob. Agents Chemother. 42: 2495-2502.
13. DEL POETA, M., W. A. SCHELL, C. C. DYKSTRA, S. K. JONES, R. R. TIDWELL et al., 1998b In vitro antifungal activity of a series of dicationic substitute carbazoles, furans and benzimidazoles. Antimicrob. Agents Chemother. 42: 2503-2510.
14. DYKSTRA, C. C., and R. R. TIDWELL, 1991 Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules. J. Protozool. 6: 78S-81S.
15. DYKSTRA, C. C., D. R. MCCLERNON, L. P. ELWELL and R. R. TIDWELL, 1994 Selective inhibition of topoisomerases from Pneumocystis carinii versus topoisomerases from mammalian cells. Antimicrob. Agents Chemother. 38: 1890-1898.
16. EDMAN, J. C., and K. J. KWON-CHUNG, 1990 Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol. Cell. Biol. 10: 4538-4544.
17. FOSTEL, J., and D. MONTGOMERY, 1995 Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicans. Antimicrob. Agents Chemother. 39: 586-592.
18. FOSTEL, J. M., D. A. MONTGOMERY and L. L. SHEN, 1992 Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery. Antimicrob. Agents Chemother. 36: 2131-2138.
19. FOSTEL, J., D. MONTGOMERY and P. LARTEY, 1996 Comparison of responses of DNA topoisomerase I from Candida albicans and human cells to four new agents which stimulate topoisomerase-dependent DNA nicking. FEMS Microbiol. Lett. 138: 105-111.
20. GERHOLD, D., M. THIYAGARAJAN and E. B. KMIEC, 1994 The topoisomerase I gene from Ustilago maydis: sequence, disruption and mutant phenotype. Nucleic Acids Res. 22: 3773-3778.
21. GOTO, T., and J. C. WANG, 1985 Cloning of yeasts TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II. Proc. Natl. Acad. Sci. USA 82: 7178-7182.
22. GUPTA, M., A. FUJIMORI and Y. POMMIER, 1995 Eukaryotic DNA topoisomerase I. Biochim. Biophys. Acta 1262: 1-14.
23. HOLM, C., T. STEARNS and D. BOTSTEIN, 1989 DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol. Cell. Biol. 9: 159-168.
24. HUSAIN, I., J. L. MOHLER, H. F. SEIGLER and J. M. BESTERMAN, 1994 Elevation of topoisomerase messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Carbohydr. Res. 54: 539-546.
25. ISHIDA, R., M. HAMATAKE, R. A. WASSERMAN, J. L. NITISS, J. C. WANG et al. 1995 DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives 1CRF-159 and 1CRF-193 in Saccharomyces cerevisiae. Cancer Res. 55: 2299-2303.
26. JIANG, W., D. GERHOLD, E. B. KMIEC, M. HAUSER, J. M. BECKER et al., 1997 The topoisomerase I gene from Candida albicans. Microbiology 143: 377-386.
27. KELLY, S. L., D. C. LAMB, M. TAYLOR, A. J. CORRAN, B. C. BALDWIN et al., 1994 Resistance to amphotericin B associated with defective sterol delta 8-7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122: 39-42.
28. KROEGER, P. E., and T. C. ROWE, 1989 Interaction of topoisomerase I with the transcribed region of the Drosophila HSP 70 heat shock gene. Nucleic Acids Res. 17: 8495-8509.
29. LEE, M. P., S. D. BROWN, A. CHEN and T. S. HSIEH, 1993 DNA topoisomerase I is essential in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 90: 6656-6660.
30. LIU, L. F., P. DUANN, C. T. LIN, P. D'ARPA and J. WU, 1996 Mechanism of action of camptothecin. Ann. NY Acad. Sci. 13: 803-844.
31. LODGE, J. K., E. JACKSON-MACHELSKI, D. L. TOFFALETTI, J. R. PERFECT and J. I. GORDON, 1994 Targeted gene replacement demonstrates that myristoyl CoA:protein N-myristoyl-transferase is essential for the viability of Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 91: 12008-12012.
32. MITCHELL, T. G., and J. R. PERFECT, 1995 Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8: 515-548.
33. MORHAM, S. G., K. D. KLUCKMAN, N. VOULOMANOS and O. SMITHIES, 1996 Targeted disruption of the mouse topoisomerase I gene by camptothecin selection. Mol. Cell. Biol. 16: 6804-6809.
34. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS, 1995 Reference method for broth dilution susceptibility testing of yeasts. Tentative Standard M27-T. NCCLS, Wayne, PA.
35. NITISS, J. L., and J. C. WANG, 1988 DNA topoisomerase-targeting antitumor drugs can be studied in yeast. Proc. Natl. Acad. Sci. USA 85: 7501-7505.
36. NITISS, J. L., Y. X. LIU and Y. HSIUNG, 1993 A temperature sensitive topoisomerase II allele confers temperature dependent drug resistant on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors. Cancer Res. 53: 89-93.
37. NITISS, J. L., A. ROSE, K. C. SYKES, J. HARRIS and J. ZHOU, 1996 Using yeast to understand drugs that target topoisomerases. Ann. NY Acad. Sci. USA 803: 32-43.
38. ODOM, A., S. MUIR, E. LIM, D. L. TOFFALETTI, J. R. PERFECT et al. 1997 Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16: 2576-2589.
39. PARUGAM, A., J. DUPOUY-CAMET, P. BLANCHE, J. P. GANGNEUX, C. TOURTE-SCHAEFER et al., 1994 Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin. Infect. Dis. 19: 975-976.
40. PERFECT, J. R., 1996 Fungal virulence genes as targets for antifungal chemotherapy. Antimicrob. Agents Chemother. 40: 1577-1583.
41. PERFECT, J. R., N. KETABCHI, G. M. COX, C. I. INGRAM and C. BEISER, 1993 Karyotyping of Cryptococcus neoformans as an epidemiological tool. J. Clin. Microbiol. 31: 3305-3309.
42. POWDERLY, W. G., 1993 Cryptococcal meningitis and AIDS. Clin. Infect. Dis. 17: 837-842.
43. REDINBO, M. R., L. STEWART, P. KUHN, J. J. CHAMPOUX and W. G. J. HOL, 1998 Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279: 1504-1513.
44. ROSE, D., W. THOMAS and C. HOLM, 1990 Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II. Cell 60: 1009-1017.
45. ROWE, T. C., E. COUTO and D. J. KROLL, 1987 Camptothecin inhibits hsp 70 heat shock transcription and induces DNA strand breaks in hsp 70 genes in Drosophila. NCI (Natl. Cancer Inst.) Monogr. 4: 49-53.
46. SAMBROOK, J., E. F. FRITSCH and T. MANIATIS, 1989 Molecular Cloning: A laboratory Manual, Ed. 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. SANGER, F., S. NICKLEN and A. R. COULSON, 1977 DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463-5467.
48. SHEN, L. L., J. BARANOWSKI, J. FOSTEL, D. A. MONTGOMERY and P. A. LARTEY, 1992 DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs. Antimicrob. Agents Chemother. 36: 2778-2784.
49. STEWART, L., M. R. REDINBO, X. QIU, W. G. J. HOL and J. J. CHAMPOUX, 1998 A model for the mechanism of human topoisomerase I. Science 279: 1534-1541.
50. SUN, Q., B. GATTO, C. YU, L. F. LIU and E. J. LA VOIE, 1994 Structure activity of topoisomerase I poisons related to Hoechst 33342. Bioorg. and Med. Chem. Lett. 4: 2871-2876.
51. TAYLOR, A., K. GILES, A. V. SARTHY, T. MCGINICAL and J. FOSTEL, 1996 Identification of the gene encoding DNA topoisomerase I from Candida albicans. FEMS Microbiol. Lett. 138: 113-121.
52. THOMPSON, J. R., C. M. DOUGLAS, N. LI, K. J. CHANG, B. PRAMANIK et al., 1999 A glucan synthase FKS1 homolog in Cryptococcus neoformans is a single copy and encodes an essential function J. Bacteriol. 181: 444-453.
53. THRASH, C., A. T. BANKIER, B. G. BARRELL and R. STERNGLANZ, 1985 Cloning, characterization, and sequence of the yeast DNA topoisomerase I gene. Proc. Natl. Acad. Sci. USA 82: 4374-4378.
54. TOFFALETTI, D. L., T. H. RUDE, S. A. JOHNSTON, D. T. DURACK and J. R. PERFECT, 1993 Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175: 1405-1411.
55. TSAO, Y-P., H-Y. WU and L. F. LIU, 1989 Transcription-driven supercoiling of DNA: direct biochemical evidence from in vitro studies. Cell 56: 111-116.
56. VEMURA, T., K. MORINO, S. UZAWA, K. SHIOZAKI and M. YANAGIDA, 1987 Cloning and sequencing of Schizosaccharomyces pombe DNA topoisomerase I gene, and effect of gene disruption. Nucleic Acids Res. 15: 9727-9739.
57. WHITE, M., C. CIRRINCIONE, A. BLEVINS and D. ARMSTRONG, 1992 Cryptococcal meningitis with AIDS and patients with neoplastic disease. J. Infect. Dis. 165: 960-966.
58. WICKES, B. L., and J. C. EDMAN, 1995 The Cryptococcus neoformans GAL7 gene and its use as an inducible promoter. Mol. Microbiol. 16: 1099-1109.